Li Zhang

5PUBLICATIONS
38CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2026
Alcohol-Induced Metabolic Stress Sensed by m6A-Modified ChREBP Drives Immune Evasion in Esophageal Carcinogenesis.

|Feb 26, 2026
A Circulating GPNMB-Based Multimodal Model Integrates Tumor-Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer.

Liang Zhu, Xiaoyuan Wang, Guoyu Cheng

|Jun 18, 2025
Clinical efficacy and biomarkers of neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma.

Siyou Deng, Qi Wang, Yueping Li

|Dec 02, 2021
GTF2E2 is a novel biomarker for recurrence after surgery and promotes progression of esophageal squamous cell carcinoma via miR-139-5p/GTF2E2/FUS axis.

Yujie Zhang, Yuxin Zhang, Bo Ai

|Dec 10, 2020
Repurposed Tocilizumab in Patients with Severe COVID-19.

Jianbo Tian, Ming Zhang, Meng Jin

Pageof 1

Frequent Collaborators

2 joint publications

Jiang Chang

1 joint publications

Jianbo Tian

1 joint publications

Ke Hu

1 joint publications

Xiaoping Miao